For the past few days, we have been discussing about the new vaccine that has been founded by the Indian Council of Medical Research (ICMR) to fight tuberculosis in adults, decades after the most famous BCG vaccine has been founded. Because the BCG vaccine has been found successful only for newborns, the ICMR decided to come up with a new vaccine specially designed for adults. While on the one hand, India has begun the clinical trial of this new tuberculosis vaccine, on the other hand, our scientists have come up with yet another startling finding.
Showing posts with label Clinical research virtual learning center Bangalore. Show all posts
Showing posts with label Clinical research virtual learning center Bangalore. Show all posts
Friday, 19 July 2019
Monday, 11 February 2019
Tisotumab Vedotin – The Cancer Killer
Cancer is one of the most prevalent diseases that patients suffer from across the globe. It could be blood cancer, breast cancer, mouth cancer, or any other kind of cancer. While there have been a lot many experiments that have been conducted over the years to help treat cancer patients, none of them have proven to kill the cancer cells completely from the body. But recently, a novel cancer drug known as “Tisotumab Vedotin” has been found which can destroy tumours from within the body. This drug has shown promising results across six different forms of cancer! These included advanced drug-resistant cancers, cervical cancers, lung cancers, bladder cancers, and ovarian cancers. This is possible because the drug releases a toxic substance to kill cancer cells from within. With the success of this drug, it has now been moved forward to the Phase-II trials, where it will be further tested in a range of additional cancer types like head, neck, bowel, pancreatic, and squamous cell lung cancers.

Subscribe to:
Posts (Atom)
